🔎 Trials Near Me

Utama › Fibrilasi Atrium › Oklahoma

Kajian klinikal Fibrilasi Atrium di Oklahoma

8 kajian untuk Fibrilasi Atrium sedang mencari peserta di lokasi di Oklahoma.

Bandar di Oklahoma

Teks kajian rasmi (Bahasa Inggeris)

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  • University of Oklahoma Health Sciences Center, Oklahoma City
Mengambil pesertaFasa 3
Umur 22 hingga 85 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05836987

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

  • Oklahoma Heart Hospital, Oklahoma City
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07527299

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

  • Oklahoma Heart Hospital, Oklahoma City
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04088071

The Fourth Left Atrial Appendage Occlusion Study

  • Saint Francis Hospital, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05963698

Detection of Atrial Fibrillation Using PPG From Smartphone Cameras

  • CardioVascular Health Clinic, Oklahoma City
Mengambil pesertaKajian pemerhatian
22 Minutes · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07779213

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  • Anthos Investigative Site 9917, Oklahoma City
Mengambil pesertaFasa 3
Umur 65 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05712200

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  • OU Medical Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
  • Ascension St. John Medical Center, Tulsa
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2026 · NCT03907046

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

  • University of Oklahoma Health Sciences Center, Oklahoma City
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 1 Apr 2026 · NCT05174052

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.